Long‐term efficacy of SGLT2 inhibitors for elderly patients with acute decompensated heart failure: The OASIS‐HF study

Long‐term efficacy of SGLT2 inhibitors for elderly patients with acute decompensated heart failure: The OASIS‐HF study

Abstract Aims Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) have been widely demonstrated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization, regardless of left ventricular ejection fraction (LVEF). However, data on the extent to which rehospitalization is suppres...

Full description

Saved in:
Bibliographic Details
Main Authors: Michitaka Amioka, Hiroki Kinoshita, Yuto Fuji, Kazuhiro Nitta, Kenichi Yamane, Tomoki Shokawa, Yukiko Nakano
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:ESC Heart Failure
Subjects:
Cardiovascular death
Ejection fraction
Heart failure
Rehospitalization
Sodium‐glucose cotransporter 2 inhibitors
Online Access:https://doi.org/10.1002/ehf2.15088
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items